INTRODUCTION
Staphylococcus aureus are recognized to be caused nosocomial & community acquired infections in every region of world. 1 Skin & Soft infections are common manifestation of Staphylococcus diseases in many community outbreaks. 2 Antibiotic resistance in Staphylococcus aureus has become an ever increasing problem. Large outbreaks of infection by Methicillin Resistant Staphylococcus aureus (MRSA) were recorded in many hospitals in Australia, USA, Britain and Ireland. Many of these outbreaks appear to have been caused by a single epidemic strain that was transferred between hospitals by the movement of patients. 3 Clindamycin is a frequent choice for treating both MRSA & MSSA infections particularly for skin & soft tissue infections and as an alternative in the penicillin allergic patients.
The Macrolide Lincosamine Streptogramin-B (MLSB) family of antibiotics is commonly used in the treatment of Staphylococcus infections. 1 Erythromycin & Clindamycin are separate antimicrobial agents their mechanisms of action (inhibition of protein synthesis) and mechanism of resistance are similar. 5 4, 6 Erythromycin are the most effective inducer of inducible MLSB resistance, Antimicrobial susceptibility data are important for the management of infections but false susceptibility result may be obtained if isolates are not tested for inducible clindamycin resistance (iMLS B ).
7
Hence this study was conducted to know the occurrence of inducible clindamycin resistance (iMLS B ) among MRSA and MSSA in this region.
MATERIALS AND METHOD
The present study was carried out in the department of Microbiology, P. 
